Avexa (AVX)


GICS industry group:     

Pharmaceuticals, Biotechnology & Life Sciences

Company Profile:  

Avexa (AVX) is a drug-discovery and development company of anti-infective pharmaceutical medicines for the treatment of serious human infectious diseases in areas such as Human Immunodeficiency Virus (HIV), Hepatitis B and Vancomycin-resistant bacterial infections.

Fat Prophets Archived Research Reports:

Report Number Publish Date
FAT-AUS-368 18 Mar 2008
FAT-AUS-365 26 Feb 2008
FAT-AUS-359 15 Jan 2008
FAT-AUS-356 11 Dec 2007
FAT-AUS-347 02 Oct 2007
FAT-AUS-341 21 Aug 2007
FAT-AUS-326 15 May 2007